Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 May;8(5):491-500.
doi: 10.1016/S1474-4422(09)70061-4.

Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic

Zheng Gang Zhang  1 , Michael Chopp
Affiliations
Review

Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic

Zheng Gang Zhang et al. Lancet Neurol. 2009 May.

Abstract

Restorative cell-based and pharmacological therapies for experimental stroke substantially improve functional outcome. These therapies target several types of parenchymal cells (including neural stem cells, cerebral endothelial cells, astrocytes, oligodendrocytes, and neurons), leading to enhancement of endogenous neurogenesis, angiogenesis, axonal sprouting, and synaptogenesis in the ischaemic brain. Interaction between these restorative events probably underpins the improvement in functional outcome. This Review provides examples of cell-based and pharmacological restorative treatments for stroke that stimulate brain plasticity and functional recovery. The molecular pathways activated by these therapies, which induce remodelling of the injured brain via angiogenesis, neurogenesis, and axonal and dendritic plasticity, are discussed. The ease of treating intact brain tissue to stimulate functional benefit in restorative therapy compared with treating injured brain tissue in neuroprotective therapy might more readily help with translation of restorative therapy from the laboratory to the clinic.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Neurogenesis in the SVZ of the lateral ventricle of adult rodent non-ischaemic and ischaemic brain tissue
A and B show sagittal and coronal views, respectively, of rat brain tissue in the SVZ. SVZ cells in the non-ischaemic brain are proliferating, as shown by BrdU-positive cells (C, arrows, brown dots). After stroke, the number of these proliferating cells increased (D, brown). Confocal microscopic images (E and F) show that BrdU-positive cells (green) are positive for doublecortin (red), indicating that these are newly generated neuroblasts. G to I show doublecortin-positive cells (red) in the ischaemic (G and H) and non-ischaemic (I) hemispheres of rats treated with erythropoietin (G) and saline (H and I). Treatment of erythropoietin substantially increased doublecortin-positive cells in the SVZ and ischaemic striatum (G). Bars are 50 μm (D), 20 μm (E), and 10 μm (F). BrdU=5-bromo-2′-deoxyuridine. CC=corpus callosum. DG=dentate gyrus. EPO=erythropoietin. LV=lateral ventricle. OB=olfactory bulb. RMS=rostral migratory stream. Str=striatum. SVZ=subventricular zone.
Figure 2
Figure 2. Stroke induces angiogenesis within the ischaemic boundary
Immunostaining with antibodies against BrdU shows proliferative endothelial cells of cerebral blood vessels (A, arrowheads). Sprouting cerebral vessels are detected with immunoreactive von Willebrand factor (B, arrowhead) and shown on three-dimensional images obtained from confocal microscopy (C, arrowheads). Proliferating endothelial cells and sprouting vessels contribute to angiogenesis seen at the ischaemic boundary region (D). D is a three-dimensional image of angiogenesis at the cortical ischaemic boundary of a rat 14 days after stroke. Bars are 10 μm (A) and 50 μm (B). BrdU=5-bromo-2'-deoxyuridine.
Figure 3
Figure 3. Cerebral angiogenesis identified with MRI and confocal images
SWI of brain coronal sections shows dark areas at the ischaemic boundary (A and D, arrowheads), which match angiogenic areas detected with confocal microscopy (B and E, arrowheads). These areas show increased CBF measured with perfusion-weighted MRI (C and F, arrowheads). All images were acquired 6 weeks after stroke from rats treated with EPO (A to C) and saline (D to F). CBF=cerebral blood flow. EPO=erythropoietin. SWI=susceptibility-weighted imaging.
Figure 4
Figure 4. Diffusion tensor imaging measurements of FA and fibre tracking
(A) A three-dimensional DTT image shows tracking of axonal projections (red) in a selected area of the CC and cortex (green). (B) A confocal image shows similar patterns of axonal projections in the same area. Treatment of stroke with sildenafil increases axonal projections (C) and FA concentrations (E, arrow) at the ischaemic boundary compared with animals treated with saline (D and F, arrow). CC=corpus callosum. DTT=diffusion tensor tractography. FA=fractional anisotropy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. NINDS Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–87. - PubMed
    1. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–29. - PubMed
    1. Kawamata T, Speliotes EK, Finklestein SP. The role of polypeptide growth factors in recovery from stroke. In: Freund H-J, Sabel BA, Witte OW, editors. Brain Plasticity. Lippincott-Raven; Philadephia: 1997. pp. 377–82. - PubMed
    1. Cramer SC, Chopp M. Recovery recapitulates ontogeny. Trends Neurosci. 2000;23:265–71. - PubMed
    1. Zhang R, Wang L, Zhang L, et al. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res. 2003;92:308–13. - PubMed

Publication types

Substances